Developer docs
API playgroundTry for free, no card

Search company profiles

Watchmaker Genomics

Full company profile

uuid0000fnq

Namestring
Watchmaker Genomics
Legal namestring
Watchmaker Genomics
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Watchmaker Genomics is a Boulder, Colorado-based biotechnology company founded in 2019 that engineers high-performance enzymes and develops integrated next-generation sequencing (NGS) workflow solutions for genomics research, clinical laboratories, and molecular diagnostics companies. Its core technology platform is built on proprietary protein engineering that produces enzymes with enhanced thermostability, inhibitor tolerance, fidelity, and processivity, combined with novel method architectures including the EquiPlex CRISPR-Cas9-based library normalization technology and the TAPS/TAPS+ TET-assisted pyridine borane sequencing chemistry for combined genetic and epigenetic analysis. The product portfolio spans DNA and RNA library preparation kits, NGS library amplification master mixes (Equinox family), library normalization kits, a tiered StellarScript reverse transcriptase portfolio, DNA polymerases, and isothermal amplification (RPA) enzymes for point-of-care diagnostics.

The company operates a primarily B2B reagent and tools business model with three revenue streams: catalog sales of NGS reagent kits and precision enzymes (direct e-commerce with quote-based pricing), custom/OEM genomic solutions (white-label kitting, custom fills, and certificates of analysis for assay developers), and technology licensing (e.g., the TAPS alliance with Exact Sciences, the CRISPR-Cas9 license from Caribou Biosciences). Distribution combines direct enterprise field sales, a global distributor network, and OEM partnerships, supported by a heavy conference and event-driven go-to-market motion across ASHG, AGBT, ESCMID, AMP, ABRF, and ESHG. Watchmaker serves a horizontal customer base including core genomics facilities, translational and clinical labs (liquid biopsy, NIPT, oncology), and molecular diagnostics assay developers, with production-scale validation at named customers such as Hartwig Medical Foundation, UMC Utrecht, Nationwide Children's Hospital, and Broad Clinical Labs. The firm holds ISO 13485:2016 certification and is venture-backed following a $40 million Series A led by Decheng Capital in June 2022, with operating headcount in the 51-100 range.

Short descriptiontext

Watchmaker Genomics is a Boulder, Colorado-based biotechnology company that engineers high-performance enzymes and integrated NGS workflow solutions for genomics research laboratories, clinical laboratories, and molecular diagnostics companies worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBoulder, United States
HQ citystring
Boulder
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
NGS library prep, DNA sequencing reagents, precision enzymes, RNA library prep, molecular diagnostics tools
Industry1 code
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Genomics Reagents and NGS Sample Preparation
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1NGS Reagent Sales
TypeOne Time License
Description

Sale of precision enzymes (reverse transcriptases, DNA polymerases, RNase inhibitors), library preparation kits (DNA and RNA), and amplification solutions to genomics research labs, clinical laboratories, and diagnostic companies.

watchmakergenomics.com
2Custom/OEM Solutions
TypeLicensing Royalties
Description

White-label kitting, custom formats, single-lot shipments, and custom certificates of analysis for assay developers and diagnostic companies requiring specialized reagent configurations.

watchmakergenomics.com
3Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary technologies including TAPS to partners like Exact Sciences for commercialization in specific application areas.

watchmakergenomics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Standard reagent kits and enzymes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products sold as kits or individual enzymes. Part numbers include standard pack sizes (e.g., T4 UvsX DNA Recombinase 7K0124-25UL, RNase H 7K0131-100UL).

watchmakergenomics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Watchmaker Genomics designs, manufactures, and sells precision enzymes, NGS library preparation kits (DNA, RNA, PCR-free, methylation), library amplification master mixes, reverse transcriptases, and isothermal amplification reagents for genomics research and clinical applications. The company also offers Custom Genomic Solutions (OEM kitting, custom fills, packaging, labeling) and licenses proprietary technologies such as TAPS to diagnostic partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 9-fold higher library yields with cfDNA compared to competing kits
+5 more records
Product overview1 text field

Watchmaker Genomics is a life sciences company developing a comprehensive portfolio of precision reagents and platforms for genomic research and clinical applications. The product portfolio spans DNA and RNA library preparation kits (including standard, fragmentation, and TAPS+ methyl-sequencing variants), NGS library amplification solutions (Equinox, Equinox Uracil-Tolerant, Equinox Prime), library normalization technologies (EquiPlex with CRISPR-based approach), reverse transcriptases (StellarScript portfolio with three thermostability tiers), DNA polymerases, and isothermal amplification enzymes (RPA). The company also offers custom genomic solutions for OEM customers. Key enabling technologies include TAPS (TET-assisted pyridine borane sequencing) for epigenetic analysis licensed from Exact Sciences, and CRISPR-Cas9 intellectual property from Caribou Biosciences for library normalization applications. Products target applications including liquid biopsy, whole genome sequencing, FFPE analysis, non-invasive prenatal testing, and infectious disease diagnostics.

Product and service16 records
1Watchmaker DNA Library Prep Kits
CategoryDNA Library Prep
Description

DNA library preparation kits that increase conversion of template DNA into sequenceable library molecules to improve coverage and sequencing economy, especially with low-input liquid biopsy samples (cfDNA and ctDNA). Streamlined and automation-friendly workflow supports robust library preparation from fragmented DNA templates.

2Watchmaker DNA Library Prep Kit with Fragmentation
CategoryDNA Library Prep
Description

DNA library preparation kit with integrated enzymatic DNA fragmentation, combining scalability and accuracy. Single-tube chemistry with reduced bias and artifacts, suited for PCR-free workflows, ultra-low inputs, and low-quality DNA samples including FFPE.

3Watchmaker DNA Library Prep Kits with TAPS+
CategoryDNA Library Prep with Methylation
Description

DNA library preparation kits with TAPS+ technology enabling direct 5mC/5hmC sequencing for combined genetic and epigenetic analysis. Powers tumor profiling and liquid biopsy applications through multimodal insights.

4Watchmaker mRNA Library Prep Kits
CategoryRNA Library Prep
Description

RNA library preparation kits featuring rapid workflow and sensitive mRNA detection. Designed for low-input and degraded samples including FFPE material.

5Equinox Library Amplification Kits
CategoryNGS Library Amplification
Description

NGS library amplification kits delivering ultra-high fidelity, low bias, and high-efficiency amplification across a wide input and GC-content range. Equinox Polymerase yields excellent fidelity, uniform sequence coverage, and high-complexity PCR products.

6Equinox Uracil-Tolerant Library Amplification Master Mix
CategoryNGS Library Amplification
Description

Uracil-tolerant amplification master mix for NGS library amplification with ultra-high fidelity and low bias. Supports methyl sequencing and other applications requiring uracil tolerance.

7EquiPlex Normalization Kit
CategoryLibrary Normalization
Description

Novel CRISPR-Cas9-based library normalization kit that simplifies library pooling at scale. Repurposes Cas9 as a stoichiometric molecular binding tool rather than cutting enzyme, capturing fixed numbers of molecules from each library regardless of starting concentration.

8Equinox Prime Library Amplification Master Mix
CategoryNGS Library Amplification
Description

Next-generation amplification solution engineered to reduce polymerase slippage in homopolymer and repetitive genomic regions prone to indel artifacts. Designed to improve variant calling accuracy in somatic oncology workflows including MSI profiling, while delivering low error rates, high library yields, and uniform GC coverage across WGS, WES, and other sequencing applications.

9StellarScript Reverse Transcriptase Portfolio
CategoryPrecision Enzymes
Description

Family of engineered M-MLV reverse transcriptase variants (StellarScript, StellarScript HT, StellarScript HT+) with reduced RNase H activity, enhanced processivity, activity, thermostability (up to 42-65°C in HT+), and inhibitor tolerance. Suitable for cDNA synthesis, RNA-seq, and point-of-care testing.

10Stellar RT-qPCR and qPCR Kits
CategoryMolecular Diagnostics Reagents
Description

RT-qPCR and qPCR kits engineered for extreme inhibitor tolerance, speed, and sensitivity. Enable extraction-free amplification and results in minutes from a range of sample types for molecular diagnostics applications.

11StellarTaq DNA Polymerase
CategoryPrecision Enzymes
Description

DNA polymerase engineered for extreme inhibitor tolerance, speed, and specificity. Available in hot start, non-hot start, and glycerol-free formats for qPCR applications with challenging sample types.

12RNase Inhibitor
CategoryPrecision Enzymes
Description

RNase inhibitor that protects RNA from degradation at temperatures up to 55°C. High-purity enzyme suited for single-cell, single-nuclei sequencing, and pathogen detection applications.

13Recombinase Polymerase Amplification (RPA) Enzymes
CategoryMolecular Diagnostics Reagents
Description

Isothermal amplification enzyme kit including T4 UvsX DNA Recombinase, T4 UvsY Protein, T4 Gene 32 Protein, and Bsu DNA Polymerase Large Fragment. Enables rapid, field-deployable molecular assays with lower amplification temperatures than LAMP.

14Whole Genome Sequencing Solutions
CategorySolution Portfolio
Description

Comprehensive whole genome sequencing portfolio including PCR-free library prep, enzymatic fragmentation, and compatibility with various sequencing platforms. Designed for applications including de novo sequencing, low-pass WGS, and human resequencing for inherited and rare diseases.

15Custom Genomic Solutions
CategoryCustom OEM Services
Description

Custom OEM capabilities including flexible fills, packaging, labeling (including white and private label), and custom certificates of analysis. Designed for developers of cutting-edge technologies requiring enzymes and reagents at scale.

16Callisto Complete Kit for DNA EF Library Prep (with Volta Labs)
CategoryIntegrated Automation Workflow
Description

Jointly developed with Volta Labs, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation to deliver a fully automated, PCR-free whole genome sequencing library preparation workflow for clinical and translational research laboratories.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-23
Description

Launched Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation platform for fully automated, PCR-free whole genome sequencing workflows targeting clinical and translational research laboratories.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-17
Description

Non-exclusive license for foundational CRISPR-Cas9 intellectual property for use in next-generation sequencing library preparation. Technology serves as programmable binding tool for NGS library normalization and PCR-free WGS applications including population genomics, newborn screening, and rare disease diagnostics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-05
Description

Strategic collaboration to develop next-generation diagnostic tests for respiratory pathogen detection in at-home setting. Combines Visby's instrument-free PCR testing technology with Watchmaker's StellarScript HT+ Reverse Transcriptase enzyme engineered for inhibitor tolerance in unprocessed clinical samples.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-05-27
Description

Partnership to simplify and streamline NGS library preparation through integration of Watchmaker's library prep solutions with SPT Labtech's automated instrumentation and consumables for life science applications.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-04-29
Description

Collaboration to deliver NGS library preparation solutions combining Watchmaker's library prep chemistry with Beckman's automated liquid handling solutions to enable labs to streamline operations and generate consistent results.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-30
Description

TAPS Technology License and Supply Alliance for commercializing TAPS (TET-assisted pyridine borane sequencing) technology for high-accuracy genomic DNA methylation analysis. Supports liquid biopsy-based cancer detection and epigenetic biomarker identification applications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Privately held manufacturer of enzymes and reagents for genomics, including DNA polymerases, ligases, and library prep kits. Directly comparable to Watchmaker across its precision enzyme portfolio and NGS reagent catalog, with a much broader catalog and deeper install base.

TypeDirect peer
Description

Roche acquired KAPA Biosystems, a direct competitor in NGS library prep enzymes and kits. KAPA's hyperactive polymerases and library prep reagents compete head-to-head with Watchmaker's Equinox and DNA library prep kits in the same core labs and clinical sequencing customers.

TypeBroad incumbent
Description

Dominant NGS platform vendor that also sells library prep reagents (e.g., DNA Prep, RNA Prep with Enrichment) bundled with its sequencing instruments. Indirect reagent competitor but the dominant channel through which many of Watchmaker's customers sequence.

TypeDirect peer
Description

Public NGS tools company offering single-cell and spatial library prep kits plus Chromium instrumentation. Competes with Watchmaker in the RNA-seq and single-cell library prep reagent market and increasingly in workflow automation.

TypeDirect peer
Description

Public synthetic DNA and NGS target enrichment company with a growing library prep and enzymatic reagent portfolio. Closely comparable as a DNA-synthesis-rooted tools company expanding into NGS sample prep chemistries.

TypeBroad incumbent
Description

Global sample-prep and molecular diagnostics reagent vendor with broad kits for DNA/RNA extraction, library prep, and PCR. Overlaps with Watchmaker's MDx tools and OEM enzyme business, particularly in clinical and translational customers.

TypeBroad incumbent
Description

Large analytical instruments and life-sciences reagents vendor covering genomics, cell analysis, and diagnostics. Competes in selected library prep, NGS QC, and OEM reagent categories for clinical and translational genomics customers.

TypeBroad incumbent
Description

Life science tools and clinical diagnostics company with a ddPCR and digital biology franchise. Competes with Watchmaker in qPCR reagents (StellarTaq/Stellar RT-qPCR) and OEM enzyme supply to diagnostics developers.

TypeBroad incumbent
Description

Life sciences and diagnostics vendor offering reagents, automation, and OEM services for genomics and cell biology. Comparable as a broader reagent-and-OEM incumbent serving translational and clinical genomics customers.

TypeEmerging player
Description

Epigenetics and methylation tools company (now part of Hologic) offering bisulfite conversion kits and methylation analysis reagents. Directly comparable to Watchmaker's TAPS/TAPS+ methylation sequencing franchise, though smaller and more niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Watchmaker Genomics

Genomics Reagents and NGS Sample Preparationwatchmakergenomics.com

Watchmaker Genomics is a Boulder, Colorado-based biotechnology company that engineers high-performance enzymes and integrated NGS workflow solutions for genomics research laboratories, clinical laboratories, and molecular diagnostics companies worldwide.

What Watchmaker Genomics does

Watchmaker Genomics is a Boulder, Colorado-based biotechnology company founded in 2019 that engineers high-performance enzymes and develops integrated next-generation sequencing (NGS) workflow solutions for genomics research, clinical laboratories, and molecular diagnostics companies. Its core technology platform is built on proprietary protein engineering that produces enzymes with enhanced thermostability, inhibitor tolerance, fidelity, and processivity, combined with novel method architectures including the EquiPlex CRISPR-Cas9-based library normalization technology and the TAPS/TAPS+ TET-assisted pyridine borane sequencing chemistry for combined genetic and epigenetic analysis. The product portfolio spans DNA and RNA library preparation kits, NGS library amplification master mixes (Equinox family), library normalization kits, a tiered StellarScript reverse transcriptase portfolio, DNA polymerases, and isothermal amplification (RPA) enzymes for point-of-care diagnostics.

The company operates a primarily B2B reagent and tools business model with three revenue streams: catalog sales of NGS reagent kits and precision enzymes (direct e-commerce with quote-based pricing), custom/OEM genomic solutions (white-label kitting, custom fills, and certificates of analysis for assay developers), and technology licensing (e.g., the TAPS alliance with Exact Sciences, the CRISPR-Cas9 license from Caribou Biosciences). Distribution combines direct enterprise field sales, a global distributor network, and OEM partnerships, supported by a heavy conference and event-driven go-to-market motion across ASHG, AGBT, ESCMID, AMP, ABRF, and ESHG. Watchmaker serves a horizontal customer base including core genomics facilities, translational and clinical labs (liquid biopsy, NIPT, oncology), and molecular diagnostics assay developers, with production-scale validation at named customers such as Hartwig Medical Foundation, UMC Utrecht, Nationwide Children's Hospital, and Broad Clinical Labs. The firm holds ISO 13485:2016 certification and is venture-backed following a $40 million Series A led by Decheng Capital in June 2022, with operating headcount in the 51-100 range.

Watchmaker Genomics firmographics

Firmographics
Name
Watchmaker Genomics
Legal name
Watchmaker Genomics
Website
https://watchmakergenomics.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
251–500 employees
Short description
Watchmaker Genomics is a Boulder, Colorado-based biotechnology company that engineers high-performance enzymes and integrated NGS workflow solutions for genomics research laboratories, clinical laboratories, and molecular diagnostics companies worldwide.
Ownership category
akta.pro rank

Watchmaker Genomics industry classification

Industry
Product category
Genomics Reagents and NGS Sample Preparation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Keywords

  • NGS library prep
  • DNA sequencing reagents
  • Precision enzymes
  • RNA library prep
  • Molecular diagnostics tools

Where Watchmaker Genomics is headquartered

Location

Headquarters

HQ city
Boulder
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Watchmaker Genomics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. NGS Reagent Sales: Sale of precision enzymes (reverse transcriptases, DNA polymerases, RNase inhibitors), library preparation kits (DNA and RNA), and amplification solutions to genomics research labs, clinical laboratories, and diagnostic companies.
  2. Custom/OEM Solutions: White-label kitting, custom formats, single-lot shipments, and custom certificates of analysis for assay developers and diagnostic companies requiring specialized reagent configurations.
  3. Technology Licensing: Licensing of proprietary technologies including TAPS to partners like Exact Sciences for commercialization in specific application areas.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard reagent kits and enzymes

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Watchmaker Genomics product offering

Product offering

Core offering

Watchmaker Genomics designs, manufactures, and sells precision enzymes, NGS library preparation kits (DNA, RNA, PCR-free, methylation), library amplification master mixes, reverse transcriptases, and isothermal amplification reagents for genomics research and clinical applications. The company also offers Custom Genomic Solutions (OEM kitting, custom fills, packaging, labeling) and licenses proprietary technologies such as TAPS to diagnostic partners.

Product overview

Watchmaker Genomics is a life sciences company developing a comprehensive portfolio of precision reagents and platforms for genomic research and clinical applications. The product portfolio spans DNA and RNA library preparation kits (including standard, fragmentation, and TAPS+ methyl-sequencing variants), NGS library amplification solutions (Equinox, Equinox Uracil-Tolerant, Equinox Prime), library normalization technologies (EquiPlex with CRISPR-based approach), reverse transcriptases (StellarScript portfolio with three thermostability tiers), DNA polymerases, and isothermal amplification enzymes (RPA). The company also offers custom genomic solutions for OEM customers. Key enabling technologies include TAPS (TET-assisted pyridine borane sequencing) for epigenetic analysis licensed from Exact Sciences, and CRISPR-Cas9 intellectual property from Caribou Biosciences for library normalization applications. Products target applications including liquid biopsy, whole genome sequencing, FFPE analysis, non-invasive prenatal testing, and infectious disease diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Watchmaker DNA Library Prep Kits DNA library preparation kits that increase conversion of template DNA into sequenceable library molecules to improve coverage and sequencing economy, especially with low-input liquid biopsy samples (cfDNA and ctDNA). Streamlined and automation-friendly workflow supports robust library preparation from fragmented DNA templates.
  • Watchmaker DNA Library Prep Kit with Fragmentation DNA library preparation kit with integrated enzymatic DNA fragmentation, combining scalability and accuracy. Single-tube chemistry with reduced bias and artifacts, suited for PCR-free workflows, ultra-low inputs, and low-quality DNA samples including FFPE.
  • Watchmaker DNA Library Prep Kits with TAPS+ DNA library preparation kits with TAPS+ technology enabling direct 5mC/5hmC sequencing for combined genetic and epigenetic analysis. Powers tumor profiling and liquid biopsy applications through multimodal insights.
  • Watchmaker mRNA Library Prep Kits RNA library preparation kits featuring rapid workflow and sensitive mRNA detection. Designed for low-input and degraded samples including FFPE material.
  • Equinox Library Amplification Kits NGS library amplification kits delivering ultra-high fidelity, low bias, and high-efficiency amplification across a wide input and GC-content range. Equinox Polymerase yields excellent fidelity, uniform sequence coverage, and high-complexity PCR products.
  • Equinox Uracil-Tolerant Library Amplification Master Mix Uracil-tolerant amplification master mix for NGS library amplification with ultra-high fidelity and low bias. Supports methyl sequencing and other applications requiring uracil tolerance.
  • EquiPlex Normalization Kit Novel CRISPR-Cas9-based library normalization kit that simplifies library pooling at scale. Repurposes Cas9 as a stoichiometric molecular binding tool rather than cutting enzyme, capturing fixed numbers of molecules from each library regardless of starting concentration.
  • Equinox Prime Library Amplification Master Mix Next-generation amplification solution engineered to reduce polymerase slippage in homopolymer and repetitive genomic regions prone to indel artifacts. Designed to improve variant calling accuracy in somatic oncology workflows including MSI profiling, while delivering low error rates, high library yields, and uniform GC coverage across WGS, WES, and other sequencing applications.
  • StellarScript Reverse Transcriptase Portfolio Family of engineered M-MLV reverse transcriptase variants (StellarScript, StellarScript HT, StellarScript HT+) with reduced RNase H activity, enhanced processivity, activity, thermostability (up to 42-65°C in HT+), and inhibitor tolerance. Suitable for cDNA synthesis, RNA-seq, and point-of-care testing.
  • Stellar RT-qPCR and qPCR Kits RT-qPCR and qPCR kits engineered for extreme inhibitor tolerance, speed, and sensitivity. Enable extraction-free amplification and results in minutes from a range of sample types for molecular diagnostics applications.
  • StellarTaq DNA Polymerase DNA polymerase engineered for extreme inhibitor tolerance, speed, and specificity. Available in hot start, non-hot start, and glycerol-free formats for qPCR applications with challenging sample types.
  • RNase Inhibitor RNase inhibitor that protects RNA from degradation at temperatures up to 55°C. High-purity enzyme suited for single-cell, single-nuclei sequencing, and pathogen detection applications.
  • Recombinase Polymerase Amplification (RPA) Enzymes Isothermal amplification enzyme kit including T4 UvsX DNA Recombinase, T4 UvsY Protein, T4 Gene 32 Protein, and Bsu DNA Polymerase Large Fragment. Enables rapid, field-deployable molecular assays with lower amplification temperatures than LAMP.
  • Whole Genome Sequencing Solutions Comprehensive whole genome sequencing portfolio including PCR-free library prep, enzymatic fragmentation, and compatibility with various sequencing platforms. Designed for applications including de novo sequencing, low-pass WGS, and human resequencing for inherited and rare diseases.
  • Custom Genomic Solutions Custom OEM capabilities including flexible fills, packaging, labeling (including white and private label), and custom certificates of analysis. Designed for developers of cutting-edge technologies requiring enzymes and reagents at scale.
  • Callisto Complete Kit for DNA EF Library Prep (with Volta Labs) Jointly developed with Volta Labs, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation to deliver a fully automated, PCR-free whole genome sequencing library preparation workflow for clinical and translational research laboratories.

Quantifiable outcome

  • 9-fold higher library yields with cfDNA compared to competing kits
  • +5 more outcomes

Companies that use Watchmaker Genomics

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Watchmaker Genomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature8 records

Watchmaker Genomics partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • Volta LabscoreTechnology or Integration · 23 February 2026Launched Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation platform for fully automated, PCR-free whole genome sequencing workflows targeting clinical and translational research laboratories.
  • Caribou BiosciencescoreTechnology or Integration · 17 February 2026Non-exclusive license for foundational CRISPR-Cas9 intellectual property for use in next-generation sequencing library preparation. Technology serves as programmable binding tool for NGS library normalization and PCR-free WGS applications including population genomics, newborn screening, and rare disease diagnostics.
  • Visby MedicalcoreStrategic or Co-development Partner · 5 February 2026Strategic collaboration to develop next-generation diagnostic tests for respiratory pathogen detection in at-home setting. Combines Visby's instrument-free PCR testing technology with Watchmaker's StellarScript HT+ Reverse Transcriptase enzyme engineered for inhibitor tolerance in unprocessed clinical samples.
  • SPT LabtechcoreTechnology or Integration · 27 May 2024Partnership to simplify and streamline NGS library preparation through integration of Watchmaker's library prep solutions with SPT Labtech's automated instrumentation and consumables for life science applications.
  • Beckman Coulter Life SciencescoreTechnology or Integration · 29 April 2024Collaboration to deliver NGS library preparation solutions combining Watchmaker's library prep chemistry with Beckman's automated liquid handling solutions to enable labs to streamline operations and generate consistent results.
  • Exact SciencescoreStrategic or Co-development Partner · 30 August 2023TAPS Technology License and Supply Alliance for commercializing TAPS (TET-assisted pyridine borane sequencing) technology for high-accuracy genomic DNA methylation analysis. Supports liquid biopsy-based cancer detection and epigenetic biomarker identification applications.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Watchmaker Genomics competitors and assessment

Company assessment

Direct peers

  • New England Biolabs: Privately held manufacturer of enzymes and reagents for genomics, including DNA polymerases, ligases, and library prep kits. Directly comparable to Watchmaker across its precision enzyme portfolio and NGS reagent catalog, with a much broader catalog and deeper install base.
  • Roche (KAPA Biosystems): Roche acquired KAPA Biosystems, a direct competitor in NGS library prep enzymes and kits. KAPA's hyperactive polymerases and library prep reagents compete head-to-head with Watchmaker's Equinox and DNA library prep kits in the same core labs and clinical sequencing customers.
  • 10x Genomics: Public NGS tools company offering single-cell and spatial library prep kits plus Chromium instrumentation. Competes with Watchmaker in the RNA-seq and single-cell library prep reagent market and increasingly in workflow automation.
  • Twist Bioscience: Public synthetic DNA and NGS target enrichment company with a growing library prep and enzymatic reagent portfolio. Closely comparable as a DNA-synthesis-rooted tools company expanding into NGS sample prep chemistries.

Broad incumbents

  • Illumina: Dominant NGS platform vendor that also sells library prep reagents (e.g., DNA Prep, RNA Prep with Enrichment) bundled with its sequencing instruments. Indirect reagent competitor but the dominant channel through which many of Watchmaker's customers sequence.
  • Qiagen: Global sample-prep and molecular diagnostics reagent vendor with broad kits for DNA/RNA extraction, library prep, and PCR. Overlaps with Watchmaker's MDx tools and OEM enzyme business, particularly in clinical and translational customers.
  • Agilent Technologies: Large analytical instruments and life-sciences reagents vendor covering genomics, cell analysis, and diagnostics. Competes in selected library prep, NGS QC, and OEM reagent categories for clinical and translational genomics customers.
  • Bio-Rad Laboratories: Life science tools and clinical diagnostics company with a ddPCR and digital biology franchise. Competes with Watchmaker in qPCR reagents (StellarTaq/Stellar RT-qPCR) and OEM enzyme supply to diagnostics developers.
  • Revvity (formerly PerkinElmer Life Sciences): Life sciences and diagnostics vendor offering reagents, automation, and OEM services for genomics and cell biology. Comparable as a broader reagent-and-OEM incumbent serving translational and clinical genomics customers.

Emerging players

  • Diagenode: Epigenetics and methylation tools company (now part of Hologic) offering bisulfite conversion kits and methylation analysis reagents. Directly comparable to Watchmaker's TAPS/TAPS+ methylation sequencing franchise, though smaller and more niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Watchmaker Genomics social profiles

Digital presence

Watchmaker Genomics compliance and trust

Trust signal

Compliance1 record

Watchmaker Genomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Watchmaker Genomics leadership team

Management profile

Number of profiles

Profiles10 records

Watchmaker Genomics funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Watchmaker Genomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Watchmaker Genomics

What does Watchmaker Genomics do?

Watchmaker Genomics designs, manufactures, and sells precision enzymes, NGS library preparation kits (DNA, RNA, PCR-free, methylation), library amplification master mixes, reverse transcriptases, and isothermal amplification reagents for genomics research and clinical applications. The company also offers Custom Genomic Solutions (OEM kitting, custom fills, packaging, labeling) and licenses proprietary technologies such as TAPS to diagnostic partners.

Is Watchmaker Genomics a public or private company?

Watchmaker Genomics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Watchmaker Genomics founded?

Watchmaker Genomics was founded in 2019. It employs 251 to 500 people.

Where is Watchmaker Genomics based?

Watchmaker Genomics is headquartered in Boulder, United States, in the North America region.

How does Watchmaker Genomics make money?

Three revenue lines are on record. NGS Reagent Sales are the primary driver. The others are custom/OEM Solutions and technology Licensing.

Who are Watchmaker Genomics's main competitors?

Direct peers on record are New England Biolabs, Roche (KAPA Biosystems), 10x Genomics and Twist Bioscience. Broad incumbents are Illumina, Qiagen, Agilent Technologies, Bio-Rad Laboratories and Revvity (formerly PerkinElmer Life Sciences). Diagenode is listed as an emerging player.

Does Watchmaker Genomics have an API?

No public API is recorded for Watchmaker Genomics.

What industry is Watchmaker Genomics in?

Watchmaker Genomics's product category is Genomics Reagents and NGS Sample Preparation. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AETOSWirePromega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse TranscriptasePromega and Watchmaker Genomics announced a strategic partnership to license a novel engineered reverse transcriptase for RNA analysis. The enzyme aims to enhance accuracy, sensitivity, and reproducibility in clinical, applied, and pharmaceutical molecular applications. The collaboration expands Promega's nucleic acid analysis portfolio.GenengnewsWatchmaker Genomics Boosts Manufacturing Capacity with Major Boulder Campus ExpansionWatchmaker Genomics signed a long-term lease for about 100,000 square feet at Flatiron Park in Boulder, Colorado, to more than double its manufacturing capacity. The facility, scheduled to become operational in the second half of 2027, will support hundreds of new Colorado jobs and house R&D, quality, and logistics functions.Lab ManagerWatchmaker Genomics to Debut CRISPR-Powered Normalization Kit and Next-Gen Amplification Mix at ESHG 2026Watchmaker Genomics announced the launch of two new products at ESHG 2026 in Gothenburg, Sweden: the EquiPlex Normalization Kit, which uses CRISPR-Cas9 as a stoichiometric molecular capture tool to eliminate manual library normalization steps, and the Equinox Prime Library Amplification Master Mix, engineered to reduce polymerase slippage artifacts in repetitive genomic regions critical for MSI profiling in oncology workflows. The company licensed foundational CRISPR-Cas9 IP from Caribou Biosciences in February 2026 specifically for the EquiPlex application, and early validation data from the Oklahoma Medical Research Foundation's Clinical Genomics Center showed the product achieved pooling consistency their conventional pipelines could not deliver. Watchmaker Genomics, founded in 2019 by veterans of Kapa Biosystems and ArcherDX, raised a $40 million Series A in 2022 and is expanding into clinical sequencing reagents.BizWestWatchmaker Genomics recognized for excellence in exporting – BizWestWatchmaker Genomics, a Boulder-based biotech, received the 2026 Governor's Award for Excellence in Exporting from Colorado officials. The company develops DNA and RNA sequencing tools and has expanded internationally. Colorado exported a record $11 billion in 2025, with trade supporting over 820,000 jobs.EIN PresswireRestriction Enzymes Market Expected to Hit US$411.4 Mn by 2033 Amid Rising Demand | Persistence Market ResearchThe global restriction enzymes market is projected to grow from US$251.2 million in 2026 to US$411.4 million by 2033, a 7.3% CAGR. North America holds 40.8% of the market, while Asia Pacific is the fastest-growing region. Type II enzymes dominate with 41.6% share, driven by cloning and sequencing applications.PR NewswireVolta Labs et Watchmaker Genomics s'associent pour présenter le kit complet Callisto™ pour la préparation des librairies ADN par EF à l'occasion d'AGBT 2026.Volta Labs and Watchmaker Genomics launched the Callisto™ Complete Kit for DNA Enzymatic Fragmentation (EF) Library Prep at the AGBT 2026 conference in Orlando, Florida, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidic automation platform. The fully automated, PCR-free whole genome sequencing (WGS) workflow is designed for clinical and translational research laboratories, eliminating manual pipetting to reduce operator variability and deliver reproducible, high-quality results. The companies held a joint presentation at the conference and plan to showcase the automated workflow directly to attendees.PR NewswireVolta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026Volta Labs and Watchmaker Genomics announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026, which automates PCR-free whole genome sequencing library preparation. The kit aims to improve accuracy and reproducibility in clinical research and translational genomics. They will host a joint presentation at AGBT 2026 to demonstrate the workflow.PR NewswireVolta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026Volta Labs and Watchmaker Genomics announced at the AGBT 2026 conference in Orlando the launch of the Callisto™ Complete Kit for DNA EF Library Prep, a fully automated PCR-free whole genome sequencing library preparation workflow. The new product combines Watchmaker's sample preparation chemistry with Volta's digital fluidics automation to enable high-quality, reproducible results without manual liquid handling. Both CEOs are quoted supporting the solution, with a joint presentation scheduled for February 24 at the conference.PR NewswireVolta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026Volta Labs and Watchmaker Genomics announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep at the AGBT General Meeting 2026 in Orlando, Florida. The product combines Watchmaker Genomics' NGS sample preparation chemistry with Volta Labs' digital fluidics automation to deliver a fully automated, PCR-free whole genome sequencing library preparation workflow targeting clinical and translational laboratories. The companies will host a joint presentation at the conference to demonstrate the automated workflow.BioSpaceVolta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026Volta Labs and Watchmaker Genomics announced a partnership to launch the Callisto™ Complete Kit for DNA EF Library Prep at the AGBT General Meeting 2026 in Orlando, Florida. The new product combines Watchmaker Genomics' NGS sample preparation chemistry with Volta Labs' digital fluidics automation to deliver a fully automated, PCR-free whole genome sequencing workflow that reduces manual liquid handling and operator variability for laboratories. The companies will host a joint presentation at AGBT 2026 on February 24 to demonstrate the automated workflow.